DNA damage in human pterygium: One-shot multiple targets

Molecular Vision

Volumn 19, Issue , 2013, Pages 348-356

  Cimpean, Anca Maria ^a   Sava, Mihai Poenaru ^a   Raica, Marius ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; PROTEIN P53; THYMINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; DNA DAMAGE; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PTERYGIUM; RECURRENT DISEASE;

ADULT; CONJUNCTIVA; DNA DAMAGE; EPITHELIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHANGIOGENESIS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PTERYGIUM; PYRIMIDINE DIMERS; RECURRENCE; STROMAL CELLS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84873908001     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Eze BI, Maduka-okafor FC, Okoye OI, Chuka-okosa CM. Pterygium: A review of clinical features and surgical treatment. Niger J Med 2011; 20:7-14. [PMID: 21970253].
2. Bradley JC, Yang W, Bradley RH, Reid TW, Schwab IR. The science of pterygia. Br J Ophthalmol 2010; 94:815-20. [PMID: 19515643].
3. Nakagami T, Murakami A, Okisaka S, Ebihara N. Mast cells in pterygium: number and phenotype. Jpn J Ophthalmol 1999; 43:75-9. [PMID: 10340786].
4. Perra MT, Maxia C, Zucca I, Piras F, Sirigu P. Immunohistochemical study of human pterygium. Histol Histopathol 2002; 17:139-49. [PMID: 11813864].
5. Pinkerton OD, Hokama Y, Shigemura LA. Immunologic basis for the pathogenesis of pterygium. Am J Ophthalmol 1984; 98:225-8. [PMID: 6383051].
6. Goodsell DS. The Molecular Perspective: Ultraviolet Light and Pyrimidine Dimers. Oncologist 2001; 6:298-9. [PMID: 11423677].
7. Mallet JD, Rochette PJ. Ultraviolet light-induced cyclobutane pyrimidine dimers in rabbit eyes. Photochem Photobiol 2011; 87:1363-8. [PMID: 21770949].
8. Tsai YY, Cheng YW, Lee H, Tsai FJ, Tseng SH, Lin CL, Chang KC. Oxidative DNA damage in pterygium. Mol Vis 2005; 11:71-5. [PMID: 15692461].
9. Strzhizhovskǐ AD. The biomedical effects of ultraviolet radiation and their mechanisms. Usp Fiziol Nauk 1995; 26:98-112. [PMID: 8525681].
10. Ko LJ, Prives C. p53: puzzle and paradigm. Genes Dev 1996; 10:1054-72. [PMID: 8654922].
11. Maltzman W, Czyzyk L. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol Cell Biol 1984; 4:1689-94. [PMID: 6092932].
12. Todd PA, Glickman BW. Mutational specificity of UV light in Escherichia coli: indications for a role of DNA secondary structure. Proc Natl Acad Sci USA 1982; 79:4123-7. [PMID: 7051003].
13. Wood RD, Skopek TR, Hutchinson F. Changes in DNA base sequence induced by targeted mutagenesis of lambda phage by ultraviolet light. J Mol Biol 1984; 173:273-91. [PMID: 6230458].
14. Sage E, Lamolet B, Brulay E, Moustacchi E, Chteauneuf A, Drobetsky EA. Mutagenic specificity of solar UV light in nucleotide excision repair-deficient rodent cells. Proc Natl Acad Sci USA 1996; 93:176-80. [PMID: 8552599].
15. Pfeifer GP. Formation and processing of UV photoproducts: effects of DNA sequence and chromatin environment. Photochem Photobiol 1997; 65:270-83. [PMID: 9066304].
16. Yoon JH, Lee CS, O'Connor TR, Yasui A, Pfeifer GP. The DNA damage spectrum produced by simulated sunlight. J Mol Biol 2000; 299:681-93. [PMID: 10835277].
17. You YH, Lee DH, Yoon JH, Nakajima S, Yasui A, Pfeifer GP. Cyclobutane pyrimidine dimers are responsible for the vast majority of mutations induced by UVB irradiation in mammalian cells. J Biol Chem 2001; 276:44688-94. [PMID: 11572873].
18. Kanjilal S, Pierceall WE, Cummings KK, Kripke ML, Ananthaswamy HN. High frequency of p53 mutations in ultraviolet radiation-induced murine skin tumors: evidence for strand bias and tumor heterogeneity. Cancer Res 1993; 53:2961-4. [PMID: 8319202].
19. van Kranen HJ, de Gruijl FR, de Vries A, Sontag Y, Wester PW, Senden HC, Rozemuller E, van Kreijl CF. Frequent p53 alterations but low incidence of ras mutations in UV-B-induced skin tumors of hairless mice. Carcinogenesis 1995; 16:1141-7. [PMID: 7767977].
20. You YH, Szabó PE, Pfeifer GP. Cyclobutane pyrimidine dimers form preferentially at the major p53 mutational hotspot in UVB-induced mouse skin tumors. Carcinogenesis 2000; 21:2113-7. [PMID: 11062176].
21. Gebhardt M, Mentlein R, Schaudig U, Pufe T, Recker K, Nölle B, Al-Samir K, Geerling G, Paulsen FP. Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia. Ophthalmology 2005; 112:1023-30. [PMID: 15885787].
22. Chui J, Coroneo MT, Tat LT, Crouch R, Wakefield D, Di Girolamo N. Ophthalmic pterygium: a stem cell disorder with premalignant features. Am J Pathol 2011; 178:817-27. [PMID: 21281814].
23. Su Y, Wang F, Qi H, Zhao SG, Li X, Cui H. Small interfering RNA targeting of S phase kinase-interacting protein 2 inhibits cell proliferation ofpterygium fibroblasts. Mol Vis 2011; 17:247-56. [PMID: 21270971].
24. Chao SC, Hu DN, Yang PY, Lin CY, Yang SF. Overexpression of urokinase-type plasminogen activator in pterygia and pterygium fibroblasts. Mol Vis 2011; 17:23-31. [PMID: 21224999].
25. An MX, Wu KL, Lin SC. Detection and comparison of matrix metalloproteinase in primary and recurrent pterygium fibroblasts. Int J Ophthalmol. 2011; 4:353-6. [PMID: 22553679].
26. Lekawa-Ilczuk A, Antosz H, Rymgayłło-Jankowska B, Zarnowski T. Expression of double strand DNA breaks repair genes in pterygium. Ophthalmic Genet 2011; 32:39-47. [PMID: 21077755].
27. Kau HC, Tsai CC, Lee CF, Kao SC, Hsu WM, Liu JH, Wei YH. Increased oxidative DNA damage, 8-hydroxydeoxy- guanosine, in human pterygium. Eye (Lond) 2006; 20:826-31. [PMID: 16113633].
28. Chen PL, Yeh KT, Tsai YY, Koeh H, Liu YL, Lee H, Cheng YW. XRCC1, but not APE1 and hOGG1 gene polymorphisms is a risk factor for pterygium. Mol Vis 2010; 16:991-6. [PMID: 20577654].
29. Chiang CC, Tsai YY, Bau DT, Cheng YW, Tseng SH, Wang RF, Tsai FJ. Pterygium and genetic polymorphisms of the DNA repair enzymes XRCC1, XPA, and XPD. Mol Vis 2010; 16:698-704. [PMID: 20431719].
30. Tsai YY, Bau DT, Chiang CC, Cheng YW, Tseng SH, Tsai FJ. Pterygium and genetic polymorphism of DNA double strand break repair gene Ku70. Mol Vis 2007; 13:1436-40. [PMID: 17768380].
31. Ribatti D, Nico B, Maxia C, Longo V, Murtas D, Mangieri D, Perra MT, De Giorgis M, Piras F, Crivellato E, Sirigu P. Neovascularization and mast cells with tryptase activity increase simultaneously in human pterygium. J Cell Mol Med 2007; 11:585-9. [PMID: 17635650].
32. Marcovich AL, Morad Y, Sandbank J, Huszar M, Rosner M, Pollack A, Herbert M, Bar-Dayan Y. Angiogenesis in pterygium: morphometric and immunohistochemical study. Curr Eye Res 2002; 25:17-22. [PMID: 12518239].
33. Aspiotis M, Tsanou E, Gorezis S, Ioachim E, Skyrlas A, Stefaniotou M, Malamou-Mitsi V. Angiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor, and thrombospondin-1. Eye (Lond) 2007; 21:1095-101. [PMID: 16823458].
34. Ribatti D, Nico B, Perra MT, Maxia C, Piras F, Murtas D, Crivellato E, Sirigu P. Correlation between NGF/TrkA and microvascular density in human pterygium. Int J Exp Pathol 2009; 90:615-20. [PMID: 19758420].
35. Naib-Majani W, Breipohl W, Shazli EE, Theuerkauf I, Pleyer U, Hahne JC, Wernert N. The Ets-1 transcription factor is involved in pterygial angiogenesis. Anat Histol Embryol 2007; 36:107-10. [PMID: 17371382].
36. Cimpean AM, Poenaru Sava M, Raica M, Ribatti D. Preliminary evidence of the presence of lymphatic vessels immunoreactive for D2-40 and Prox-1 in human pterygium. Oncol Rep 2011; 26:[PMID: 21667034].
37. Bielenberg DR, Bucana CD, Sanchez R, Donawho CK, Kripke ML, Fidler IJ. Molecular regulation of UVB-induced cutaneous angiogenesis. J Invest Dermatol 1998; 111:864-72. [PMID: 9804351].
38. Sawane M, Kajiya K. Ultraviolet light-induced changes of lymphatic and blood vasculature in skin and their molecular mechanisms. Exp Dermatol 2012; 21:Suppl 122-5. [PMID: 22626467].
39. Kajiya K, Kidoya H, Sawane M, Matsumoto-Okazaki Y, Yamanishi H, Furuse M, Takakura N. Promotion of lymphatic integrity by angiopoietin-1/Tie2 signaling during inflammation. Am J Pathol 2012; 180:1273-82. [PMID: 22200616].
40. Smith ML, Kumar MA. The "Two faces" of Tumor Suppressor p53-revisited. Mol Cell Pharmacol. 2010; 2:117-9. [PMID: 20686673].
41. Smith ML, Fornace AJ Jr. The two faces of tumor suppressor p53. Am J Pathol 1996; 148:1019-22. [PMID: 8644842].
42. Smith ML, Fornace AJ Jr. p53-mediated protective responses to UV irradiation. Proc Natl Acad Sci USA 1997; 94:12255-7. [PMID: 9356435].
43. Smith ML, Chen IT, Zhan Q, O'Connor PM, Fornace AJ Jr. Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage. Oncogene 1995; 10:1053-9. [PMID: 7700629].
44. Smith ML, Ford JM, Hollander MC, Bortnick RA, Amundson SA, Seo YR, Deng CX, Hanawalt PC, Fornace AJ Jr. p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/or gadd45 genes. Mol Cell Biol 2000; 20:3705-14. [PMID: 10779360].
45. Dushku N, Reid TW. P53 expression in altered limbal basal cells of pingueculae, pterygia, and limbal tumors. Curr Eye Res 1997; 16:1179-92. [PMID: 9426949].
46. Seo YR, Fishel ML, Amundson SA, Kelley MR, Smith ML. Implication of p53 in base excision DNA repair: in vivo evidence. Oncogene 2002; 21:731-7. [PMID: 11850801].